Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Schering-Plough Corporation is a holding company whose subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. Discovery and development efforts target the field of human health. Occasionally, applications in the field of animal health can result from these efforts. The Company views animal health applications as a means to maximize the return on investments in discovery and development. The Company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the Company has sought and may in the future seek regulatory approval to switch prescription products to over-the-counter (OTC) status as a means of extending a product's life cycle. In this way, the OTC marketplace is yet another means of maximizing the return on investments in discovery and development.

Financial Information
SGP is engaged in the discovery, development, manufacturing and marketing of pharmaceutical and health care products worldwide, including prescription drugs, animal health, over-the-counter, foot care and sun care products. For the six months ended 6/02, revenues rose 9% to $5.39 billion. Net income rose 3% to $1.23 billion. Results reflect sales growth of anti-infective and anitcancer products, partially offset by increased SG&A and R&D expenses.